Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6286326

NCCCC[C@@](N)(C(=O)Nc1ccc(C(c2ccc(NC(=O)[C@](N)(CCCCN)C(=O)c3cccc4ccccc34)cc2)c2ccc(NC(=O)[C@](N)(CCCCN)C(=O)c3cccc4ccccc34)cc2)cc1)C(=O)c1cccc2ccccc12.O=C(O)C(F)(F)F

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 1/20 0.37
KLK1 P06870 4/20 0.36
KLK5 Q9Y337 2/20 0.36
DEGS1 O15121 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
PLG P00747 2/20 0.34
KLK6 Q92876 2/20 0.34
BACE1 P56817 2/20 0.34
ELANE P08246 1/20 0.34
CA12 O43570 1/20 0.33
CA2 P00918 1/20 0.33
CA9 Q16790 1/20 0.33
F2 P00734 1/20 0.33
PTGDR2 Q9Y5Y4 1/20 0.33
PLA2G2D Q9UNK4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL7039294 0.88 KLK1 (0.39) KLK1KLK5MEN1KMT2ANPC1
Trifluoroacetic Acid SCHEMBL6287884 0.86 KEAP1 (0.37) KLK1KLK5MEN1KMT2ANPC1
Trifluoroacetic Acid SCHEMBL6290918 0.86 MLYCD (0.37) KLK1KLK5MEN1KMT2ANPC1
Trifluoroacetic Acid SCHEMBL6287794 0.86 MLYCD (0.37) KLK1KLK5MEN1KMT2ANPC1
Trifluoroacetic Acid SCHEMBL7039259 0.84 GABRB1 (0.40) NR1H4DEGS1MEN1KMT2ANPC1
Trifluoroacetic Acid SCHEMBL7038495 0.83 TP53 (0.35) KLK1KLK5NPC1RAB9AF2
SCHEMBL6290435 0.81 EGFR (0.34) KLK1DEGS1PLGKLK6
SCHEMBL6290421 0.81 EGFR (0.34) KLK1DEGS1PLGKLK6
Trifluoroacetic Acid SCHEMBL6288018 0.80 CES1 (0.39) NPC1RAB9ACA12CA2CA9
Trifluoroacetic Acid SCHEMBL6286281 0.80 CES1 (0.39) NPC1RAB9ACA12CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6887890-B2 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2005-05-03 US disclosed
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-08-28 US disclosed
EP-1291341-A1 COMPOUNDS EXHIBITING THROMBOPOIETIN-LIKE ACTIVITIES CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-03-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities MPL, THPO, TEK NR1H4 3735/4885KLK1 2324/4885KLK5 3413/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.